Concepedia

Ventzislav Vassilev

VV

Statistics

Publications

17

Citations

1K

H-Index

15

Active since

1993

Affiliations

GlaxoSmithKline (Belgium)(Current)

University of Nebraska–Lincoln

CEINGE Biotecnologie Avanzate Franco Salvatore (Italy)

GlaxoSmithKline (United States)

University of Oxford

Ventzislav Vassilev is an author at GlaxoSmithKline (Belgium) specializing in infectious diseases, veterinary medicine, and vaccinology.

Publications per year

1993–2021

17

Publications

17

Randomized Trial of a Vaccine Regimen to Prevent Chronic HCV Infection

Kimberly Page, Michael T. Melia, Rebecca T. Veenhuis et al. · New England Journal of Medicine · 2021 · 166 citations · Full text

, , +16

A Phase 1/2 Clinical Trial Evaluating Safety and Immunogenicity of a Varicella Zoster Glycoprotein E Subunit Vaccine Candidate in Young and Older Adults

Isabel Leroux‐Roels, Geert Leroux‐Roels, Frédéric Clément et al. · The Journal of Infectious Diseases · 2012 · 147 citations · Full text

, , +17

The Amino-Terminal Domain of Bovine Viral Diarrhea Virus N<sup>pro</sup>Protein Is Necessary for Alpha/Beta Interferon Antagonism

Laura H. V. G. Gil, Israr-ul H. Ansari, Ventzislav Vassilev et al. · Journal of Virology · 2005 · 97 citations · Full text

, , +17

Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine versus one dose of monovalent varicella vaccine: a multicentre, observer-blind, randomised, controlled trial

Roman Prymula, Marianne Riise Bergsaker, Susanna Esposito et al. · The Lancet · 2014 · 95 citations

, , +14

The envelope glycoprotein E2 is a determinant of cell culture tropism in ruminant pestiviruses

Delin Liang, I. Fernández Sainz, Israr-ul H. Ansari et al. · Journal of General Virology · 2003 · 81 citations

, , +16

1–5 of 17